U.S. markets open in 4 hours 36 minutes
  • S&P Futures

    4,248.75
    +3.00 (+0.07%)
     
  • Dow Futures

    34,479.00
    +17.00 (+0.05%)
     
  • Nasdaq Futures

    14,023.50
    +29.25 (+0.21%)
     
  • Russell 2000 Futures

    2,333.20
    -0.70 (-0.03%)
     
  • Crude Oil

    71.65
    +0.74 (+1.04%)
     
  • Gold

    1,858.60
    -21.00 (-1.12%)
     
  • Silver

    27.82
    -0.33 (-1.16%)
     
  • EUR/USD

    1.2117
    +0.0010 (+0.08%)
     
  • 10-Yr Bond

    1.4620
    0.0000 (0.00%)
     
  • Vix

    16.03
    -0.07 (-0.43%)
     
  • GBP/USD

    1.4079
    -0.0037 (-0.26%)
     
  • USD/JPY

    109.6330
    -0.0020 (-0.00%)
     
  • BTC-USD

    39,634.36
    +4,055.48 (+11.40%)
     
  • CMC Crypto 200

    985.82
    +44.01 (+4.67%)
     
  • FTSE 100

    7,158.36
    +24.30 (+0.34%)
     
  • Nikkei 225

    29,161.80
    +213.07 (+0.74%)
     

CLASS ACTION UPDATE for SOS, KDMN and ACAD: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders

  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.
·4 min read
  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.

NEW YORK, NY / ACCESSWIRE / May 13, 2021 / Levi & Korsinsky, LLP announces that class action lawsuits have commenced on behalf of shareholders of the following publicly-traded companies. Shareholders interested in serving as lead plaintiff have until the deadlines listed to petition the court. Further details about the cases can be found at the links provided. There is no cost or obligation to you.

SOS Shareholders Click Here: https://www.zlk.com/pslra-1/sos-limited-information-request-form?prid=15811&wire=1
KDMN Shareholders Click Here: https://www.zlk.com/pslra-1/kadmon-holdings-inc-loss-submission-form?prid=15811&wire=1
ACAD Shareholders Click Here: https://www.zlk.com/pslra-1/acadia-pharmaceuticals-inc-loss-submission-form?prid=15811&wire=1

* ADDITIONAL INFORMATION BELOW *

SOS Limited (NYSE:SOS)

SOS Lawsuit on behalf of: investors who purchased July 22, 2020 - February 25, 2021
Lead Plaintiff Deadline : June 1, 2021
TO LEARN MORE, VISIT: https://www.zlk.com/pslra-1/sos-limited-information-request-form?prid=15811&wire=1

According to the filed complaint, during the class period, SOS Limited made materially false and/or misleading statements and/or failed to disclose that: (i) SOS had misrepresented the true nature, location, and/or existence of at least one of the principal executive offices listed in its SEC filings; (ii) HY and FXK were either undisclosed related parties and/or entities fabricated by the Company; (iii) the Company had misrepresented the type and/or existence of the mining rigs that it claimed to have purchased; and (iv) as a result, the Company's public statements were materially false and misleading at all relevant times.

Kadmon Holdings, Inc. (NASDAQ:KDMN)

KDMN Lawsuit on behalf of: investors who purchased October 1, 2020 - March 10, 2021
Lead Plaintiff Deadline : June 2, 2021
TO LEARN MORE, VISIT: https://www.zlk.com/pslra-1/kadmon-holdings-inc-loss-submission-form?prid=15811&wire=1

According to the filed complaint, during the class period, Kadmon Holdings, Inc. made materially false and/or misleading statements and/or failed to disclose that: (i) the Belumosudil NDA was incomplete and/or deficient; (ii) the additional new data that the Company submitted in support of the Belumosudil NDA in response to an information request from the FDA materially altered the NDA submission; (iii) accordingly, the initial Belumosudil NDA submission lacked the degree of support that the Company had led investors to believe; (iv) accordingly, the FDA was likely to extend the PDUFA target action date to review the Belumosudil NDA; and (v) as a result, the Company's public statements were materially false and misleading at all relevant times.

Acadia Pharmaceuticals Inc. (NASDAQ:ACAD)

ACAD Lawsuit on behalf of: investors who purchased June 15, 2020 - April 4, 2021
Lead Plaintiff Deadline : June 18, 2021
TO LEARN MORE, VISIT: https://www.zlk.com/pslra-1/acadia-pharmaceuticals-inc-loss-submission-form?prid=15811&wire=1

According to the filed complaint, during the class period, Acadia Pharmaceuticals Inc. made materially false and/or misleading statements and/or failed to disclose that: (i) the materials submitted in support of the pimavanserin sNDA contained statistical and design deficiencies; (ii) accordingly, the pimavanserin sNDA lacked the evidentiary support that the Company had led investors to believe it possessed; (iii) the FDA was unlikely to approve the pimavanserin sNDA in its present form; and (iv) as a result, the Company's public statements were materially false and misleading at all relevant times.

You have until the lead plaintiff deadlines to request that the court appoint you as lead plaintiff. Your ability to share in any recovery doesn't require that you serve as a lead plaintiff.

Levi & Korsinsky is a nationally recognized firm with offices in New York, California, Connecticut, and Washington D.C. The firm's attorneys have extensive expertise and experience representing investors in securities litigation and have recovered hundreds of millions of dollars for aggrieved shareholders. Attorney advertising. Prior results do not guarantee similar outcomes.

CONTACT:
Levi & Korsinsky, LLP
Joseph E. Levi, Esq.
55 Broadway, 10th Floor
New York, NY 10006
jlevi@levikorsinsky.com
Tel: (212) 363-7500
Fax: (212) 363-7171
www.zlk.com

SOURCE: Levi & Korsinsky, LLP



View source version on accesswire.com:
https://www.accesswire.com/647183/CLASS-ACTION-UPDATE-for-SOS-KDMN-and-ACAD-Levi-Korsinsky-LLP-Reminds-Investors-of-Class-Actions-on-Behalf-of-Shareholders